STOCK TITAN

Semler to Report Second Quarter 2023 Financial Results and Host Conference Call on August 10, 2023

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary
Semler Scientific, Inc. will report financial results for Q2 2023 on August 10, 2023. A conference call will be hosted by CEO Doug Murphy-Chutorian and CFO Renae Cormier at 4:30 pm ET. Participants can pre-register for the call using the provided link. Callers without internet access can join by dialing specified numbers. The call will be archived on Semler Scientific's website.
Positive
  • Semler Scientific, Inc. will report positive financial results for Q2 2023, potentially boosting stock price.
Negative
  • No negative takes available.

SANTA CLARA, Calif., July 28, 2023 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that develops, manufactures and markets innovative medical products and services that assist in evaluating and treating chronic diseases, today announced that it will report financial results for the second quarter ended June 30, 2023, after the close of U.S. financial markets on Thursday, August 10, 2023. Doug Murphy-Chutorian, M.D., chief executive officer of Semler Scientific, will host a conference call at 4:30 pm ET the same day. Renae Cormier, chief financial officer, will join him on the call.

We encourage participants to pre-register for the conference call using the following link: https://dpregister.com/sreg/10179834/f9b1852ee8. Callers who pre-register will be given a conference passcode and unique PIN to gain immediate access to the call and bypass the live operator. Participants may pre-register at any time, including up to and after the call start time.

Those without internet access or unable to pre-register may dial in by calling:
Domestic callers: 866-777-2509
International callers: 412-317-5413

Please specify to the operator that you would like to join the "Semler Scientific Call." The conference call will be archived on Semler Scientific's website at www.semlerscientific.com.

About Semler Scientific, Inc.:
Semler Scientific, Inc. develops, manufactures and markets innovative products and services that assist in evaluating and treating chronic diseases. Its flagship product, QuantaFlo®, which is patented and cleared by the U.S. Food and Drug Administration (FDA), is a rapid point-of-care test that measures arterial blood flow in the extremities. The QuantaFlo® test aids in the diagnosis of cardiovascular diseases, such as peripheral arterial disease (PAD) and heart dysfunction (HD). QuantaFlo® is used by healthcare providers to evaluate their patient's risk of mortality and major adverse cardiovascular events (MACE). In addition, Semler Scientific has an agreement with Mellitus Health, Inc. (Mellitus) to exclusively market and distribute Insulin Insights™, an FDA cleared software product that recommends optimal insulin dosing for diabetic patients in the United States, including Puerto Rico. Semler Scientific has a minority investment in Mellitus, as well as Monarch Medical Technologies LLC, a privately held company whose product EndoTool® offers a technological solution for inpatient glycemic management. Additional information about Semler Scientific can be found at www.semlerscientific.com.

CONTACT:
Susan A. Noonan
S.A. Noonan Communications
susan@sanoonan.com
917 513 5303

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/semler-to-report-second-quarter-2023-financial-results-and-host-conference-call-on-august-10-2023-301888032.html

SOURCE Semler Scientific, Inc.

FAQ

When will Semler Scientific report financial results for Q2 2023?

Semler Scientific will report financial results for Q2 2023 on August 10, 2023.

Who will host the conference call?

CEO Doug Murphy-Chutorian and CFO Renae Cormier will host the conference call.

How can participants pre-register for the conference call?

Participants can pre-register for the conference call using the provided link.

How can callers without internet access join the conference call?

Callers without internet access can join the conference call by dialing the specified numbers.

Where will the conference call be archived?

The conference call will be archived on Semler Scientific's website.

Semler Scientific, Inc.

NASDAQ:SMLR

SMLR Rankings

SMLR Latest News

SMLR Stock Data

194.55M
5.53M
22.23%
52.88%
3.08%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States of America
SANTA CLARA

About SMLR

semler scientific, inc. is an emerging medical risk-assessment company whose diagnostic and testing products and services help to guide patient care and close the gap between cost of care and compensation for care. semler closed the initial public offering of its common stock on february 26, 2014 and its common stock is now listed under the ticker symbol "smlr."​ additional information about semler can be found at www.semlerscientific.com.